DXS INTERNATIONAL PLC (AQSE: DXSP): Trading Update

Summary by AI BETAClose X

DXS International plc expects its financial year to 30 April 2026 to show group turnover of approximately £3.4 million, marginally lower than the previous year primarily due to reduced R&D tax credit income, but anticipates a small profit, a significant improvement from the prior year's £90,000 loss, reflecting operational discipline and cost control. The company's balance sheet has strengthened through debt-to-equity conversions, and its new NexGen referral solution is showing positive results with ten pilot deployments active and a 94% form completion rate, leading to early user adoption. Despite short-term delays in NHS decision-making due to restructuring, DXS sees long-term opportunities as Integrated Care Boards consolidate, and existing agreements have been extended to September 2027, with the company remaining positive about future growth prospects.

Disclaimer*

UK 100

Latest directors dealings